[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Sarcopenia Supplement Market Research Report 2023

December 2023 | 91 pages | ID: G5E929F29E7FEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sarcopenia is a type of muscle loss (muscle atrophy) that occurs with aging and/or immobility.

According to QYResearch’s new survey, global Sarcopenia Supplement market is projected to reach US$ 3670 million in 2029, increasing from US$ 2762.8 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sarcopenia Supplement market research.

The Sarcopenia Supplement market is primarily driven by the aging global population and the increasing awareness of age-related muscle loss. Sarcopenia supplements, designed to support muscle health and prevent muscle deterioration, cater to the growing demand for proactive approaches to healthy aging. The desire to maintain mobility, independence, and overall quality of life among the elderly population contributes to market growth. However, challenges include the need for well-researched and evidence-based formulations that effectively address muscle loss. Navigating regulatory requirements and ensuring consumer trust in supplement efficacy are ongoing concerns. Moreover, the market faces competition from various dietary and lifestyle interventions for muscle health. The market's success hinges on scientific advancements in supplement formulation, rigorous clinical testing, and educational efforts to inform both consumers and healthcare professionals about the benefits and appropriate use of sarcopenia supplements.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sarcopenia Supplement market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Abbott Laboratories
  • Nestlй
  • Pfizer
  • Amway
  • By-health
  • Usana
  • A&Z Pharmaceutical
  • GlaxoSmithKline
  • Bayer
  • H&H
  • Blackmores
  • Zhendong Group
Segment by Type
  • Protein Supplement
  • Calcium Supplement
  • Other
Segment by Application
  • Online Pharmacies
  • Retail Pharmacies
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Sarcopenia Supplement report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Sarcopenia Supplement Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Protein Supplement
  1.2.3 Calcium Supplement
  1.2.4 Other
1.3 Market by Application
  1.3.1 Global Sarcopenia Supplement Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Online Pharmacies
  1.3.3 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Sarcopenia Supplement Market Perspective (2018-2029)
2.2 Sarcopenia Supplement Growth Trends by Region
  2.2.1 Global Sarcopenia Supplement Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Sarcopenia Supplement Historic Market Size by Region (2018-2023)
  2.2.3 Sarcopenia Supplement Forecasted Market Size by Region (2024-2029)
2.3 Sarcopenia Supplement Market Dynamics
  2.3.1 Sarcopenia Supplement Industry Trends
  2.3.2 Sarcopenia Supplement Market Drivers
  2.3.3 Sarcopenia Supplement Market Challenges
  2.3.4 Sarcopenia Supplement Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Sarcopenia Supplement Players by Revenue
  3.1.1 Global Top Sarcopenia Supplement Players by Revenue (2018-2023)
  3.1.2 Global Sarcopenia Supplement Revenue Market Share by Players (2018-2023)
3.2 Global Sarcopenia Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sarcopenia Supplement Revenue
3.4 Global Sarcopenia Supplement Market Concentration Ratio
  3.4.1 Global Sarcopenia Supplement Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Sarcopenia Supplement Revenue in 2022
3.5 Sarcopenia Supplement Key Players Head office and Area Served
3.6 Key Players Sarcopenia Supplement Product Solution and Service
3.7 Date of Enter into Sarcopenia Supplement Market
3.8 Mergers & Acquisitions, Expansion Plans

4 SARCOPENIA SUPPLEMENT BREAKDOWN DATA BY TYPE

4.1 Global Sarcopenia Supplement Historic Market Size by Type (2018-2023)
4.2 Global Sarcopenia Supplement Forecasted Market Size by Type (2024-2029)

5 SARCOPENIA SUPPLEMENT BREAKDOWN DATA BY APPLICATION

5.1 Global Sarcopenia Supplement Historic Market Size by Application (2018-2023)
5.2 Global Sarcopenia Supplement Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Sarcopenia Supplement Market Size (2018-2029)
6.2 North America Sarcopenia Supplement Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sarcopenia Supplement Market Size by Country (2018-2023)
6.4 North America Sarcopenia Supplement Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Sarcopenia Supplement Market Size (2018-2029)
7.2 Europe Sarcopenia Supplement Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sarcopenia Supplement Market Size by Country (2018-2023)
7.4 Europe Sarcopenia Supplement Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Sarcopenia Supplement Market Size (2018-2029)
8.2 Asia-Pacific Sarcopenia Supplement Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sarcopenia Supplement Market Size by Region (2018-2023)
8.4 Asia-Pacific Sarcopenia Supplement Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Sarcopenia Supplement Market Size (2018-2029)
9.2 Latin America Sarcopenia Supplement Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sarcopenia Supplement Market Size by Country (2018-2023)
9.4 Latin America Sarcopenia Supplement Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Sarcopenia Supplement Market Size (2018-2029)
10.2 Middle East & Africa Sarcopenia Supplement Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sarcopenia Supplement Market Size by Country (2018-2023)
10.4 Middle East & Africa Sarcopenia Supplement Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Detail
  11.1.2 Abbott Laboratories Business Overview
  11.1.3 Abbott Laboratories Sarcopenia Supplement Introduction
  11.1.4 Abbott Laboratories Revenue in Sarcopenia Supplement Business (2018-2023)
  11.1.5 Abbott Laboratories Recent Development
11.2 Nestlй
  11.2.1 Nestlй Company Detail
  11.2.2 Nestlй Business Overview
  11.2.3 Nestlй Sarcopenia Supplement Introduction
  11.2.4 Nestlй Revenue in Sarcopenia Supplement Business (2018-2023)
  11.2.5 Nestlй Recent Development
11.3 Pfizer
  11.3.1 Pfizer Company Detail
  11.3.2 Pfizer Business Overview
  11.3.3 Pfizer Sarcopenia Supplement Introduction
  11.3.4 Pfizer Revenue in Sarcopenia Supplement Business (2018-2023)
  11.3.5 Pfizer Recent Development
11.4 Amway
  11.4.1 Amway Company Detail
  11.4.2 Amway Business Overview
  11.4.3 Amway Sarcopenia Supplement Introduction
  11.4.4 Amway Revenue in Sarcopenia Supplement Business (2018-2023)
  11.4.5 Amway Recent Development
11.5 By-health
  11.5.1 By-health Company Detail
  11.5.2 By-health Business Overview
  11.5.3 By-health Sarcopenia Supplement Introduction
  11.5.4 By-health Revenue in Sarcopenia Supplement Business (2018-2023)
  11.5.5 By-health Recent Development
11.6 Usana
  11.6.1 Usana Company Detail
  11.6.2 Usana Business Overview
  11.6.3 Usana Sarcopenia Supplement Introduction
  11.6.4 Usana Revenue in Sarcopenia Supplement Business (2018-2023)
  11.6.5 Usana Recent Development
11.7 A&Z Pharmaceutical
  11.7.1 A&Z Pharmaceutical Company Detail
  11.7.2 A&Z Pharmaceutical Business Overview
  11.7.3 A&Z Pharmaceutical Sarcopenia Supplement Introduction
  11.7.4 A&Z Pharmaceutical Revenue in Sarcopenia Supplement Business (2018-2023)
  11.7.5 A&Z Pharmaceutical Recent Development
11.8 GlaxoSmithKline
  11.8.1 GlaxoSmithKline Company Detail
  11.8.2 GlaxoSmithKline Business Overview
  11.8.3 GlaxoSmithKline Sarcopenia Supplement Introduction
  11.8.4 GlaxoSmithKline Revenue in Sarcopenia Supplement Business (2018-2023)
  11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
  11.9.1 Bayer Company Detail
  11.9.2 Bayer Business Overview
  11.9.3 Bayer Sarcopenia Supplement Introduction
  11.9.4 Bayer Revenue in Sarcopenia Supplement Business (2018-2023)
  11.9.5 Bayer Recent Development
11.10 H&H
  11.10.1 H&H Company Detail
  11.10.2 H&H Business Overview
  11.10.3 H&H Sarcopenia Supplement Introduction
  11.10.4 H&H Revenue in Sarcopenia Supplement Business (2018-2023)
  11.10.5 H&H Recent Development
11.11 Blackmores
  11.11.1 Blackmores Company Detail
  11.11.2 Blackmores Business Overview
  11.11.3 Blackmores Sarcopenia Supplement Introduction
  11.11.4 Blackmores Revenue in Sarcopenia Supplement Business (2018-2023)
  11.11.5 Blackmores Recent Development
11.12 Zhendong Group
  11.12.1 Zhendong Group Company Detail
  11.12.2 Zhendong Group Business Overview
  11.12.3 Zhendong Group Sarcopenia Supplement Introduction
  11.12.4 Zhendong Group Revenue in Sarcopenia Supplement Business (2018-2023)
  11.12.5 Zhendong Group Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Sarcopenia Supplement Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Protein Supplement
Table 3. Key Players of Calcium Supplement
Table 4. Key Players of Other
Table 5. Global Sarcopenia Supplement Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Sarcopenia Supplement Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Sarcopenia Supplement Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sarcopenia Supplement Market Share by Region (2018-2023)
Table 9. Global Sarcopenia Supplement Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Sarcopenia Supplement Market Share by Region (2024-2029)
Table 11. Sarcopenia Supplement Market Trends
Table 12. Sarcopenia Supplement Market Drivers
Table 13. Sarcopenia Supplement Market Challenges
Table 14. Sarcopenia Supplement Market Restraints
Table 15. Global Sarcopenia Supplement Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sarcopenia Supplement Market Share by Players (2018-2023)
Table 17. Global Top Sarcopenia Supplement Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Supplement as of 2022)
Table 18. Ranking of Global Top Sarcopenia Supplement Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sarcopenia Supplement Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sarcopenia Supplement Product Solution and Service
Table 22. Date of Enter into Sarcopenia Supplement Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sarcopenia Supplement Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sarcopenia Supplement Revenue Market Share by Type (2018-2023)
Table 26. Global Sarcopenia Supplement Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Sarcopenia Supplement Revenue Market Share by Type (2024-2029)
Table 28. Global Sarcopenia Supplement Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sarcopenia Supplement Revenue Market Share by Application (2018-2023)
Table 30. Global Sarcopenia Supplement Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Sarcopenia Supplement Revenue Market Share by Application (2024-2029)
Table 32. North America Sarcopenia Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Sarcopenia Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sarcopenia Supplement Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Sarcopenia Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Sarcopenia Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sarcopenia Supplement Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Sarcopenia Supplement Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Sarcopenia Supplement Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sarcopenia Supplement Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Sarcopenia Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Sarcopenia Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sarcopenia Supplement Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Sarcopenia Supplement Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Sarcopenia Supplement Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sarcopenia Supplement Market Size by Country (2024-2029) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Sarcopenia Supplement Product
Table 50. Abbott Laboratories Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Nestlй Company Detail
Table 53. Nestlй Business Overview
Table 54. Nestlй Sarcopenia Supplement Product
Table 55. Nestlй Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 56. Nestlй Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Sarcopenia Supplement Product
Table 60. Pfizer Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Amway Company Detail
Table 63. Amway Business Overview
Table 64. Amway Sarcopenia Supplement Product
Table 65. Amway Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 66. Amway Recent Development
Table 67. By-health Company Detail
Table 68. By-health Business Overview
Table 69. By-health Sarcopenia Supplement Product
Table 70. By-health Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 71. By-health Recent Development
Table 72. Usana Company Detail
Table 73. Usana Business Overview
Table 74. Usana Sarcopenia Supplement Product
Table 75. Usana Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 76. Usana Recent Development
Table 77. A&Z Pharmaceutical Company Detail
Table 78. A&Z Pharmaceutical Business Overview
Table 79. A&Z Pharmaceutical Sarcopenia Supplement Product
Table 80. A&Z Pharmaceutical Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 81. A&Z Pharmaceutical Recent Development
Table 82. GlaxoSmithKline Company Detail
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Sarcopenia Supplement Product
Table 85. GlaxoSmithKline Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bayer Company Detail
Table 88. Bayer Business Overview
Table 89. Bayer Sarcopenia Supplement Product
Table 90. Bayer Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. H&H Company Detail
Table 93. H&H Business Overview
Table 94. H&H Sarcopenia Supplement Product
Table 95. H&H Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 96. H&H Recent Development
Table 97. Blackmores Company Detail
Table 98. Blackmores Business Overview
Table 99. Blackmores Sarcopenia Supplement Product
Table 100. Blackmores Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 101. Blackmores Recent Development
Table 102. Zhendong Group Company Detail
Table 103. Zhendong Group Business Overview
Table 104. Zhendong Group Sarcopenia Supplement Product
Table 105. Zhendong Group Revenue in Sarcopenia Supplement Business (2018-2023) & (US$ Million)
Table 106. Zhendong Group Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Sarcopenia Supplement Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Sarcopenia Supplement Market Share by Type: 2022 VS 2029
Figure 3. Protein Supplement Features
Figure 4. Calcium Supplement Features
Figure 5. Other Features
Figure 6. Global Sarcopenia Supplement Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Sarcopenia Supplement Market Share by Application: 2022 VS 2029
Figure 8. Online Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Sarcopenia Supplement Report Years Considered
Figure 11. Global Sarcopenia Supplement Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Sarcopenia Supplement Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Sarcopenia Supplement Market Share by Region: 2022 VS 2029
Figure 14. Global Sarcopenia Supplement Market Share by Players in 2022
Figure 15. Global Top Sarcopenia Supplement Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Supplement as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sarcopenia Supplement Revenue in 2022
Figure 17. North America Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Sarcopenia Supplement Market Share by Country (2018-2029)
Figure 19. United States Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Sarcopenia Supplement Market Share by Country (2018-2029)
Figure 23. Germany Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Sarcopenia Supplement Market Share by Region (2018-2029)
Figure 31. China Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Sarcopenia Supplement Market Share by Country (2018-2029)
Figure 39. Mexico Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Sarcopenia Supplement Market Share by Country (2018-2029)
Figure 43. Turkey Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Sarcopenia Supplement Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 46. Nestlй Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 48. Amway Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 49. By-health Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 50. Usana Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 51. A&Z Pharmaceutical Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 54. H&H Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 55. Blackmores Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 56. Zhendong Group Revenue Growth Rate in Sarcopenia Supplement Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


More Publications